Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 2
Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs
Romain Aymon, Denis Mongin, Romain Guemara, Zubeyir Salis, Johan Askling, Denis Choquette, Catalin Codreanu, Daniela Di Giuseppe, Irini Flouri, Doreen Huschek, Žiga Rotar
Izvirni znanstveni članek
Oznake: adverse cardiovascular events;rheumatoid arthritis;patients;Janus kinase inhibitors;biologic disease-modifying antirheumatic drugs;"JAK-pot" study;
Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs
Leto: 2025 Vir: Repozitorij Univerze v Ljubljani (RUL)
Evolution of Janus Kinase inhibitors (JAKi) prescriptions since 2015 in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study)
Denis Mongin, Denis Mongin, Denis Choquette, Louis Coupal, Catalin Codreanu, Florenzo Iannone, Sella A Provan, Tore K. Kvien, Ruth Fritsch-Stork, Dan C. Nordström, Žiga Rotar
Izvirni znanstveni članek
Oznake: drug safety regulation;Janus kinase inhibitors;registry;rheumatoid arthritis;drug prescription;
Background: Janus kinase inhibitors (JAKi) are effective for treating rheumatoid arthritis (RA), but post-marketing safety concerns have triggered regulatory warnings and updated guidelines. The impact of these communications on real-world prescribing remains unclear. Objectives: To assess the impac ...
Leto: 2026 Vir: Medicinska fakulteta (UL MF)
Št. zadetkov: 2
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: